AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12407136 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate (4 mg/kg/day for 3 days)
Number of subjects: 2
Study 12407136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 10037133 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated specific treponemal test (PK‐TP)
Number of subjects: 4878215
Study 10037133 — intervention group
Group type: COMPARATOR
Intervention: Rapid plasma reagin test (RPR)
Number of subjects: 4878215
Study 10037133 — intervention group
Group type: EXPERIMENTAL
Intervention: PK‐TP test
Number of subjects: 4878215
Study 10037133 — intervention group
Group type: EXPERIMENTAL
Intervention: Serologic testing for syphilis
Number of subjects: 4878215
Study 7548288 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% podophyllotoxin cream (Condyline), applied twice daily for three days in weekly intervals
Number of subjects: 60
Study 7548288 — intervention group
Group type: COMPARATOR
Intervention: 20% podophyllin solution, applied weekly
Number of subjects: 60
Study 7548288 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% podophyllotoxin cream (Condyline)
Number of subjects: 60
Study 7548288 — intervention group
Group type: COMPARATOR
Intervention: 20% podophyllin solution
Number of subjects: 60
Study 1657111 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART)
Number of subjects: 0
Study 1657111 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of chemotherapy and radiotherapy
Number of subjects: 0
Study 7033559 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptotriad
Number of subjects: 0
Study 7033559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7033559 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismutum
Number of subjects: 0
Study 7033559 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethacridine
Number of subjects: 0
Study 7033559 — intervention group
Group type: EXPERIMENTAL
Intervention: Fultrexine
Number of subjects: 0
Study 7033559 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphadoxine
Number of subjects: 0
Study 7033559 — intervention group
Group type: EXPERIMENTAL
Intervention: Difenoxine
Number of subjects: 0
Study 6376719 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX followed one hour later by 5‐FU
Number of subjects: 108
Study 6376719 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU followed one hour later by MTX
Number of subjects: 108
Study 29507942 — intervention group
Group type: EXPERIMENTAL
Intervention: IV methylprednisolone sodium succinate (1000-mg)
Number of subjects: 55
Study 29507942 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone (1250-mg)
Number of subjects: 55
Study 27430605 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intercostal nerve block (ICNB) followed by catheter-based infusion of 0.5% bupivacaine
Number of subjects: 66
Study 27430605 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) analgesia alone
Number of subjects: 66
Study 24913161 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole (6 mg/kg IV q12h for 24h followed by 4 mg/kg IV q12h, switched to 300 mg orally q12h as appropriate)
Number of subjects: 305
Study 24913161 — intervention group
Group type: EXPERIMENTAL
Intervention: Anidulafungin (200 mg loading dose followed by 100 mg IV q24h)
Number of subjects: 305
Study 24913161 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 305
Study 23730580 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal spray and nasal breathing exercise (NBE)
Number of subjects: 60
Study 23730580 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate nasal spray
Number of subjects: 60
Study 20547444 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone (2x12 mg within 24 h)
Number of subjects: 8
Study 18095262 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based physical training intervention
Number of subjects: 132
Study 15970873 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical, transurethral radiofrequency energy (RF) tissue micro-remodeling
Number of subjects: 0
Study 15970873 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 0
Study 12834861 — intervention group
Group type: EXPERIMENTAL
Intervention: 1x 125 mg oral brivudin for 7 days
Number of subjects: 608
Study 12834861 — intervention group
Group type: COMPARATOR
Intervention: 5x 800 mg acyclovir for 7 days
Number of subjects: 608
Study 11304051 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg elemental zinc (n = 136)
Number of subjects: 274
Study 11304051 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 138)
Number of subjects: 274
Study 8681923 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized breast cancer risk counseling (BCRC)
Number of subjects: 239
Study 8681923 — intervention group
Group type: COMPARATOR
Intervention: General health education (GHE)
Number of subjects: 239
Study 8681923 — intervention group
Group type: EXPERIMENTAL
Intervention: BCRC and GHE groups
Number of subjects: 239
Study 2072191 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-intraoral landmark technique (EIL technique)
Number of subjects: 0
Study 2072191 — intervention group
Group type: COMPARATOR
Intervention: Direct technique
Number of subjects: 0
Study 6823630 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural pethidine 0.75 mg/kg
Number of subjects: 41
Study 6823630 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular pethidine 1.5 mg/kg
Number of subjects: 41
Study 31607294 — intervention group
Group type: EXPERIMENTAL
Intervention: Decitabine combined with half-course pre-excitation treatment
Number of subjects: 44
Study 31607294 — intervention group
Group type: COMPARATOR
Intervention: Routine complete course pre-excitation treatment (Control)
Number of subjects: 44
Study 28645203 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurosurgical procedures
Number of subjects: 401
Study 27965223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (meditation, mild yoga movement, and music), conducted in a group format 1 hour a week for 8 weeks.
Number of subjects: 0
Study 27965223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 0
Study 27965223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (meditation, mild yoga movement, and music).
Number of subjects: 0
Study 24533082 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (25 g; PRO)
Number of subjects: 8
Study 24533082 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1.5 g·kg body mass⁻¹) co-ingested with protein (ALC-PRO)
Number of subjects: 8
Study 24533082 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1.5 g·kg body mass⁻¹) co-ingested with carbohydrate (ALC-CHO)
Number of subjects: 8
Study 24533082 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-matched quantity of carbohydrate (25 g maltodextrin; ALC-CHO)
Number of subjects: 8
Study 24533082 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 8
Study 22279217 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 18
Study 22279217 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 18
Study 22279217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 20206849 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX‐MDZ (Dexmedetomidine with midazolam)
Number of subjects: 55
Study 20206849 — intervention group
Group type: COMPARATOR
Intervention: MDZ (Midazolam only)
Number of subjects: 55
Study 17419955 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive‐expressive group therapy (SEGT)
Number of subjects: 0
Study 17419955 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 0
Study 16387985 — intervention group
Group type: EXPERIMENTAL
Intervention: controlled‐release fluvoxamine
Number of subjects: 117
Study 11940738 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus hypothermia for 48 hrs
Number of subjects: 392
Study 11940738 — intervention group
Group type: COMPARATOR
Intervention: Standard brain injury treatment
Number of subjects: 392
Study 9639217 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion of normal saline (37 degrees C) at 600 ml/h for 1 h, then 180 ml/h until full cervical dilatation or uterine baseline activity reached 20 mm Hg.
Number of subjects: 42
Study 9639217 — intervention group
Group type: COMPARATOR
Intervention: Control group (no amnioinfusion).
Number of subjects: 42
Study 9639217 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion group.
Number of subjects: 42
Study 9639217 — intervention group
Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 42
Study 8018108 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 energy percent of fat food regimen
Number of subjects: 20
Study 8018108 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 energy percent of fat food regimen
Number of subjects: 20
Study 8018108 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance physical activity
Number of subjects: 20
Study 8018108 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline dietary fiber intake
Number of subjects: 20
Study 2738182 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoamine oxidase inhibitors (MAOIs)
Number of subjects: 18
Study 1059709 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated vaccine
Number of subjects: 1048
Study 1059709 — intervention group
Group type: EXPERIMENTAL
Intervention: Detergent-split subunit vaccine
Number of subjects: 1048
Study 1059709 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 1048
Study 31812490 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (15 minutes twice per day during phototherapy)
Number of subjects: 50
Study 31812490 — intervention group
Group type: COMPARATOR
Intervention: Routine care during phototherapy
Number of subjects: 50
Study 30552112 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab in combination with trastuzumab and chemotherapy
Number of subjects: 381
Study 30552112 — intervention group
Group type: COMPARATOR
Intervention: Placebo in combination with trastuzumab and chemotherapy
Number of subjects: 381
Study 28376288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 148
Study 28376288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 26547464 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared physician-patient incentives
Number of subjects: 1503
Study 26547464 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician incentives
Number of subjects: 1503
Study 26547464 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient incentives
Number of subjects: 1503
Study 26547464 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1503
Study 23389565 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer navigation (CN) techniques
Number of subjects: 33
Study 23389565 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic (fluoro) techniques
Number of subjects: 33
Study 21888861 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 953
Study 21888861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 953
Study 19793402 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg scopolamine
Number of subjects: 12
Study 19793402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 16814414 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg twice daily)
Number of subjects: 216
Study 16814414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 14971981 — intervention group
Group type: EXPERIMENTAL
Intervention: rollerboard training
Number of subjects: 58
Study 14971981 — intervention group
Group type: COMPARATOR
Intervention: control group (14 cross-country runners)
Number of subjects: 58
Study 14971981 — intervention group
Group type: EXPERIMENTAL
Intervention: other training methods (weight, circuit, ski-specific)
Number of subjects: 58
Study 11578715 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 0
Study 11578715 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban with unfractionated heparin
Number of subjects: 0
Study 11578715 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 0
Study 11578715 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study 9406135 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic use of pancreatic enzyme-sodium bicarbonate suspension (5 mL containing lipase 2000 FIP units, amylase 1500 FIP units, protease 100 FIP units, and 90 mg NaHCO3)
Number of subjects: 57
Study 9406135 — intervention group
Group type: COMPARATOR
Intervention: Water flushing (control)
Number of subjects: 57
Study 8482047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelin-1 alone (5 pmol/min)
Number of subjects: 6
Study 8482047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelin-1 + Glyceryl trinitrate
Number of subjects: 6
Study 8482047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelin-1 + NG-mononmethyl-L-arginine
Number of subjects: 6
Study 8482047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelin-1 + Prostacyclin
Number of subjects: 6
Study 8482047 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelin-1 + Aspirin (acetylsalicylic acid)
Number of subjects: 6
Study 3025113 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline therapy (sustained release preparation, TheoDur 200 and 300 mg)
Number of subjects: 10
Study 3025113 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 10
Study 3025113 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline therapy (sustained release preparation)
Number of subjects: 10
Study 29127072 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy with a repetition frequency of 2.05Hz and a maximum flux density of 25.3μT (rms)
Number of subjects: 70
Study 29127072 — intervention group
Group type: COMPARATOR
Intervention: Sham PEMF (placebo)
Number of subjects: 70
Study 26640157 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses
Number of subjects: 102
Study 26640157 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocker‐sole footwear
Number of subjects: 102
Study 26640157 — intervention group
Group type: COMPARATOR
Intervention: Usual footwear
Number of subjects: 102
Study 24709491 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg orally, tid for 7 days)
Number of subjects: 128
Study 24709491 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo, 10 mL of sterile water for injection, tid for 7 days)
Number of subjects: 128
Study 22495138 — intervention group
Group type: EXPERIMENTAL
Intervention: New atrial fibrillation
Number of subjects: 30424
Study 22495138 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 30424
Study 18820825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone for 8 weeks
Number of subjects: 24
Study 18820825 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued previous treatment)
Number of subjects: 24
Study 17666353 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation with FGF rate of 1 L/min, setting concentration 1%
Number of subjects: 60
Study 17666353 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation with FGF rate of 1 L/min, setting concentration 2%
Number of subjects: 60
Study 17666353 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation with FGF rate of 2 L/min, setting concentration 1%
Number of subjects: 60
Study 17666353 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation with FGF rate of 2 L/min, setting concentration 2%
Number of subjects: 60
Study 17666353 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation with FGF rate of 3 L/min, setting concentration 1%
Number of subjects: 60
Study 17666353 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation with FGF rate of 3 L/min, setting concentration 2%
Number of subjects: 60
Study 15031839 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic group
Number of subjects: 20
Study 15031839 — intervention group
Group type: EXPERIMENTAL
Intervention: WAD group
Number of subjects: 20
Study 15031839 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 12759210 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest (EVH)
Number of subjects: 60
Study 12759210 — intervention group
Group type: COMPARATOR
Intervention: Open vein harvest (OVH)
Number of subjects: 60
Study 7641897 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin plus HRT (25 micrograms transdermal 17 beta E2 daily and 5 mg medroxyprogesterone acetate orally daily) for 20 weeks
Number of subjects: 50
Study 7641897 — intervention group
Group type: COMPARATOR
Intervention: Goserelin alone, 3.6 mg SC depot every 4 weeks for 24 weeks
Number of subjects: 50
Study 7641897 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin, 3.6 mg SC depot every 4 weeks for 24 weeks, plus HRT
Number of subjects: 50
Study 2590331 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression
Number of subjects: 20
Study 2590331 — intervention group
Group type: COMPARATOR
Intervention: Open acromioplasty
Number of subjects: 20
Study 790943 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic porcine secretin, 333 mug subcutaneously every 4 hr for 10 days
Number of subjects: 13
Study 790943 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections on the same schedule
Number of subjects: 13
Study 30062527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection (1 ml of 2% mepivacaine and 40 mg of triamcinolone)
Number of subjects: 56
Study 30062527 — intervention group
Group type: COMPARATOR
Intervention: Blind injection (1 ml of 2% mepivacaine and 40 mg of triamcinolone)
Number of subjects: 56
Study 27366978 — intervention group
Group type: EXPERIMENTAL
Intervention: Boppy condition (positional support using a Mini Boppy®)
Number of subjects: 32
Study 27366978 — intervention group
Group type: COMPARATOR
Intervention: Roll condition (rolled blanket)
Number of subjects: 32
Study 27366978 — intervention group
Group type: COMPARATOR
Intervention: Blanket condition (flat blanket)
Number of subjects: 32
Study 24206541 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive multifactorial non‐pharmacologic interventions including better compliance with prescribed medication, regular blood pressure measurements, healthy diet, regular physical activity, and cognitive training.
Number of subjects: 202
Study 24206541 — intervention group
Group type: COMPARATOR
Intervention: Standard stroke care according to guidelines (control group).
Number of subjects: 202
Study 23680739 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 716
Study 23680739 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 716
Study 23680739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 716
Study 21510308 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 IE Heparin (0.2 ml of 25000 IE)
Number of subjects: 89
Study 21510308 — intervention group
Group type: COMPARATOR
Intervention: 0.2 ml 0.9% NaCL (placebo)
Number of subjects: 89
Study 21510308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 21510308 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 89
Study 18608554 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangerine tomato sauce (300 g per day)
Number of subjects: 21
Study 18608554 — intervention group
Group type: COMPARATOR
Intervention: Red tomato sauce (300 g per day)
Number of subjects: 21
Study 18608554 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tomato sauces
Number of subjects: 21
Study 16768659 — intervention group
Group type: EXPERIMENTAL
Intervention: FOBT
Number of subjects: 1679
Study 16768659 — intervention group
Group type: EXPERIMENTAL
Intervention: FOBT/FS
Number of subjects: 1679
Study 16768659 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC
Number of subjects: 1679
Study 16768659 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 1679
Study 16768659 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of test with FOBT kit
Number of subjects: 1679
Study 16768659 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of test without FOBT kit
Number of subjects: 1679
Study 15330955 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg kg(‐1) intramuscular midazolam by Bioject injector
Number of subjects: 45
Study 15330955 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg kg(‐1) subcutaneous midazolam by J‐Tip injector
Number of subjects: 45
Study 15330955 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg kg(‐1) oral midazolam
Number of subjects: 45
Study 11519531 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine N-butylbromide (10 mg p.o. t.i.d. for 24 h)
Number of subjects: 20
Study 11519531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11367646 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvia Miltiorrhizae Composita (SMC) 200 mg/kg administered intravenously before operation and during rewarming period
Number of subjects: 18
Study 11367646 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (control group)
Number of subjects: 18
Study 7921099 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including home visits weekly during the first year and biweekly thereafter, and attendance at a child development center 5 days a week from 12 months to 3 years
Number of subjects: 914
Study 7921099 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 914
Study 2454118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group (CB)
Number of subjects: 0
Study 2454118 — intervention group
Group type: COMPARATOR
Intervention: Attention-placebo group
Number of subjects: 0
Study 2454118 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0